Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Kymera inks deal with Gilead as partnership with Sanofi faces a switch-up
2 weeks ago
R&D
Arbutus regains rights to hepatitis B asset in China; Forte’s $75M offering
2 weeks ago
News Briefing
BrightGene seeks a partner for Zepbound-beating obesity shot
2 weeks ago
R&D
Bayer's stem cell group BlueRock restructures pipeline, lays off staffers
2 weeks ago
People
Cell/Gene Tx
Biogen unveils first data from Spinraza follow-on, plans late-stage program
2 weeks ago
R&D
FDA investigating Sarepta’s Duchenne gene therapy following patient deaths
2 weeks ago
Cell/Gene Tx
FDA+
RFK Jr. pledges to keep the US at the center of the biotech 'revolution'
3 weeks ago
Pharma
Former FDA scientist and psychedelics researcher hired as CDER deputy director
3 weeks ago
People
FDA+
RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing
3 weeks ago
Pharma
FDA+
Novo and Hims' crossed wires
3 weeks ago
Health Tech
Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders
3 weeks ago
People
Startups
Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say
3 weeks ago
FDA+
Revolution inks up to $2B 'flexible' funding deal to advance RAS inhibitor pipeline
3 weeks ago
Financing
Deals
Nektar's mid-stage eczema data deliver key win in bid for company turnaround
3 weeks ago
R&D
ArriVent plots next steps for lung cancer drug; Neuron23's $96.5M raise
3 weeks ago
News Briefing
UK government blueprints ambition to be a key life sciences hub
3 weeks ago
R&D
Pharma
Nuvalent closes in on FDA filing for lung cancer drug with topline Phase 1/2 data
3 weeks ago
R&D
The politics of vaccination take center stage as RFK Jr.’s rebuilt CDC panel is set to meet
3 weeks ago
FDA+
Updated: Amgen plans lower, slower MariTide doses for obesity drug’s Phase 3
3 weeks ago
R&D
AstraZeneca, Daiichi Sankyo gain lung cancer indication for Enhertu successor
3 weeks ago
Pharma
FDA+
Roche plans to pit next-gen hemophilia A antibody against Hemlibra in Phase 3
3 weeks ago
R&D
Supreme Court asks DOJ to weigh in on Hikma ‘skinny label’ fight against Amarin
3 weeks ago
Pharma
Law
Exelixis' positive Phase 3 colorectal cancer data boost stock
3 weeks ago
R&D
Novo ends short-lived partnership with Hims over compounded obesity drugs
3 weeks ago
Startups
Pharma
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page